Myelodysplastic syndromes trials in Israel

In Israel 6 Also abroad 369

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Where
Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
225 worldwide
Run by
Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Haifa, Jerusalem, Tel Aviv
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 2Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Where
Ramat Gan, Tel Aviv
Age
18 years and over
People
210 worldwide
Run by
Takeda
See details and how to joinNCT04419649 · EU 2023-507469-24-00
No phaseTaking people
Early Detection and Screening of Hematological Malignancies - SANGUINE
Where
Tel Aviv
Age
18 years and over
People
3,000 worldwide
Run by
JaxBio Ltd
See details and how to joinNCT05735704
Phase 3Taking people
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Where
Afula, Haifa, Jerusalem, Nahariya, Petah Tikva
Age
18 years and over
People
665 worldwide
Run by
Celgene
See details and how to joinNCT04064060
Phase 1Taking people
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
Where
Jerusalem
Age
18 years to 100 years
People
15
Run by
Minovia Therapeutics Ltd.
See details and how to joinNCT06465160